Cian Healthcare (BOM:542678) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:542678 Cian Healthcare Ltd BOM:542678
45 GF Score
Price ₹15.48
GF Value ₹8.27
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Cian Healthcare Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

BOM:542678
45GF Score
Cian Healthcare Ltd BOM:542678
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cian Healthcare (BOM:542678) Overvalued in 2026?

Based on GuruFocus' analysis, Cian Healthcare stock appears to be overvalued. The current stock price of ₹15.48 is trading 87.2% above its estimated GF Value™ of ₹8.27. GuruFocus considers Cian Healthcare to be Significantly Overvalued.

Key valuation signals for BOM:542678:

  • Dividends Received:
  • GF Value™: ₹8.27 vs. price of ₹15.48 (87.2% above fair value)
  • GF Score™: 45/100 with 6 warning signs

No single metric tells the full story. See the BOM:542678 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cian Healthcare Business Description

Address Mundhwa Kharadi Road, Kirtane Baugh, Office No 301 Konark Icon 3rd Floor, Magarpatta Hadapsar, Mundhwa, Pune, MH, IND, 411036
Cian Healthcare Ltd is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products. The company manufactures multiple product lines, including tablets, capsules, soft gels, liquid orals, ointments/creams and sachets, and cosmetics. Its portfolio comprises gynecology, haematinic, cardio-diabetic, orthopedic, pediatric, dermacosmetic, antibiotic, CNS, vitamins, and nutrient products. The company operates in five sectors: Export, Government Supplies, Merchant Export, Own Brand Franchise Business, and Third Party/Contract Manufacturing.
45GF Score

Get the complete analysis for BOM:542678

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.48
Price
₹8.27
GF Value